The purpose of this webinar is to describe the process of coding for PrEP in WV and PA, discuss the implementation of billing for PrEP, and compare the different options for paying for PrEP.
This webinar will focus on the question of why there is a raging epidemic of addiction. The current opioid epidemic is a symptom of the fraying of the socio-economic fabric of rural United States. We will also look at the reasons why funding should be targeted to substance misuse, not to the drug of the moment.
At the end of the webinar, participants will be able to describe current guidelines and epidemiology for HIV testing among adolescents, identify key steps in educating health professionals on routine HIV testing for adolescents, and discuss lessons learned and how to implement these lessons learned across EHE regions.
This session will describe PrEP and the importance of adherence during the COVID-19 pandemic, barriers to PrEP that have been brought on by COVID-19, strategies to overcome barriers and promote adherence, and how telehealth can be used to promote PrEP.
This webinar will describe the process of vaccine development during COVID-19 and discuss the challenges and opportunities associated with vaccine development.
Abstract: Prescription drug misuse and opioid overdose death have increased significantly in recent years. Many states have implemented Prescription Drug Monitoring Programs (PDMPs) as a means to improve prescribing practices and mediate the ongoing opioid crisis in the United States (US). This comprehensive literature review examines the current structure of state-run PDMPs, and legislation surrounding them. More specifically, the Pennsylvania PDMP is examined. Limitations and barriers to use of PDMPs are explored. Recommendations are provided for improving current state-run PDMPs, and a proposal is made for the development of a national-level prescription drug monitoring database.
Public Health Significance: The implementation of a standardized national-level prescription drug monitoring database could have a significant impact on reducing accessible opioids and other substances in the community. This could reduce opioid overdose death rates as discussed in prior studies of the effects of current state-run programs. A national program could also have an impact on decreasing the spread of infectious diseases such as HIV and Hepatitis C. Literature supports an association between substance use and increased risk of engaging in needle sharing and risky sexual behavior while under the influence of drugs or in seeking drugs. Improving accessibility of patient prescription data through a national database could lead to improved prescribing/tapering of opioid drugs, and improved screening and treatment for substance use, therefore preventing the progression from prescription drug misuse to injection drug use.
Advisor: Dr. Linda Frank
Last Updated On Tuesday, April 17, 2018 by Abby Kincaid
Created On Tuesday, April 3, 2018
Click to enter calendar events or share news and announcements.